Stocks/DNLI/Filings & Earnings

DNLI SEC Filings, Earnings & Splits

Key events from SEC filings, earnings beat/miss history, stock split records, and share float data for DNLI.

What are DNLI's recent SEC filings?

8-K · OtherNov 3, 2026

Denali Therapeutics issued a press release announcing its financial results for the third quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.

View full filing details →
10-Q · OtherNov 3, 2026

Denali Therapeutics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures including cash position, investments, and collaboration agreements.

View full filing details →

Has DNLI ever done a stock split?

No stock splits are recorded for DNLI.

What is DNLI's share float?

Shares Outstanding
$159.8M

Get Real-Time DNLI Intelligence

SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.

Try SEPT X-Ray Free

More DNLI Research

DNLI FundamentalsDNLI AnalysisSEPT Academy
Share:XRedditFacebookLinkedIn
© SEPT Investing. Filing summaries are extracted automatically from SEC filings and may contain errors. Always verify with official SEC EDGAR filings. Trading involves risk.